Evidence map›Paper›PMID 31747680›Full record

ArticleNature2019

A new antibiotic selectively kills Gram-negative pathogens.

Yu Imai, Kirsten J Meyer, Akira Iinishi, Quentin Favre-Godal, Robert Green, Sylvie Manuse, Mariaelena Caboni, Miho Mori, Samantha Niles, Meghan Ghiglieri and 20 more

Erratum issuedAbstract read
In one paragraph

Article in Nature, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 380 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
380citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

380 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Drug-resistantClinical microbiology reviews · 2025
    Pooled it
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. A mechanism for substrate quality control in outer membrane protein assembly.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  18. Article
  19. Discovery of HAdvanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Article
  20. Review

320 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

30 authors.

Yu ImaiAntimicrobial Discovery Center, Department of Biology, Northeastern University, Boston, MA, USA.
Kirsten J MeyerAntimicrobial Discovery Center, Department of Biology, Northeastern University, Boston, MA, USA.
Akira IinishiAntimicrobial Discovery Center, Department of Biology, Northeastern University, Boston, MA, USA.
Quentin Favre-GodalAntimicrobial Discovery Center, Department of Biology, Northeastern University, Boston, MA, USA.
Robert GreenAntimicrobial Discovery Center, Department of Biology, Northeastern University, Boston, MA, USA.
Sylvie ManuseAntimicrobial Discovery Center, Department of Biology, Northeastern University, Boston, MA, USA.
Mariaelena CaboniAntimicrobial Discovery Center, Department of Biology, Northeastern University, Boston, MA, USA.
Miho MoriAntimicrobial Discovery Center, Department of Biology, Northeastern University, Boston, MA, USA.
Samantha NilesAntimicrobial Discovery Center, Department of Biology, Northeastern University, Boston, MA, USA.
Meghan GhiglieriAntimicrobial Discovery Center, Department of Biology, Northeastern University, Boston, MA, USA.
Chandrashekhar HonraoCenter for Drug Discovery, Department of Pharmaceutical Sciences, Northeastern University, Boston, MA, USA.
Xiaoyu MaCenter for Drug Discovery, Department of Pharmaceutical Sciences, Northeastern University, Boston, MA, USA.
Jason J GuoCenter for Drug Discovery, Department of Pharmaceutical Sciences, Northeastern University, Boston, MA, USA.
Alexandros MakriyannisCenter for Drug Discovery, Department of Pharmaceutical Sciences, Northeastern University, Boston, MA, USA.
Luis Linares-OtoyaInstitute for Insect Biotechnology, Justus-Liebig-University of Giessen, Giessen, Germany.
Nils BöhringerInstitute for Insect Biotechnology, Justus-Liebig-University of Giessen, Giessen, Germany.
Zerlina G WuisanInstitute for Insect Biotechnology, Justus-Liebig-University of Giessen, Giessen, Germany.
Hundeep KaurBiozentrum, University of Basel, Basel, Switzerland.
Runrun WuPurdue Institute of Inflammation, Immunology and Infectious Disease, Purdue University, West Lafayette, IN, USA.
André MateusGenome Biology Unit, European Molecular Biology Laboratory, Heidelberg, Germany.
Athanasios TypasGenome Biology Unit, European Molecular Biology Laboratory, Heidelberg, Germany.
Mikhail M SavitskiGenome Biology Unit, European Molecular Biology Laboratory, Heidelberg, Germany.
Josh L EspinozaDepartment of Human Biology, J. Craig Venter Institute, La Jolla, CA, USA.
Aubrie O'RourkeDepartment of Human Biology, J. Craig Venter Institute, La Jolla, CA, USA.
Karen E NelsonDepartment of Human Biology, J. Craig Venter Institute, La Jolla, CA, USA.
Sebastian HillerBiozentrum, University of Basel, Basel, Switzerland.
Nicholas NoinajPurdue Institute of Inflammation, Immunology and Infectious Disease, Purdue University, West Lafayette, IN, USA.
Till F SchäberleInstitute for Insect Biotechnology, Justus-Liebig-University of Giessen, Giessen, Germany.
Anthony D'OnofrioAntimicrobial Discovery Center, Department of Biology, Northeastern University, Boston, MA, USA.
Kim LewisAntimicrobial Discovery Center, Department of Biology, Northeastern University, Boston, MA, USA. k.lewis@neu.edu.

Funding

Uncultured bacteria for the discovery of novel antimicrobialsP01AI118687 · NIAID · NORTHEASTERN UNIVERSITY · PI LEWIS, KIM · 2016 to 2020
$8.9M
Structural Characterization of the TOC Protein Translocon MachineryR01GM127896 · NIGMS · PURDUE UNIVERSITY · PI NOINAJ, NICHOLAS · 2018 to 2022
$1.5M
Unraveling the mechanism by which the BAM complex mediates OMP biogenesisR01GM127884 · NIGMS · PURDUE UNIVERSITY · PI NOINAJ, NICHOLAS · 2019 to 2022
$1.2M
NIAID NIH HHS P01 AI118687NIGMS NIH HHS R01 GM127884NIGMS NIH HHS R01 GM127896NIH HHS GM127884NIH HHS GM127896
6 · The paper itself

Abstract

The current need for novel antibiotics is especially acute for drug-resistant Gram-negative pathogens

Indexed as

AnimalsAnti-Bacterial AgentsBacterial Outer Membrane ProteinsCell LineDisease Models, AnimalDrug DiscoveryDrug Resistance, MicrobialEscherichia coli ProteinsFemaleGastrointestinal MicrobiomeGram-Negative BacteriaHumansMiceMicrobial Sensitivity TestsMicrobial ViabilityMutationAnti-Bacterial AgentsBacterial Outer Membrane ProteinsBamA protein, E colidarobactinEscherichia coli ProteinsPhenylpropionates

Identifiers

PMID31747680
PMCPMC7188312

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.